  | Kaux, J.-F., Croisier, J.-L., Bruyère, O., Rodriguez de la Cruz, C., Forthomme, B., Brabant, G., Lapraille, S., Lonneux, V., Noel, D., Le Goff, C., Gothot, A., COLLETTE, J., & Crielaard, J.-M. (September 2015). One injection of platelet-rich plasma associated to a submaximal eccentric protocol to treat chronic jumper's knee. Journal of Sports Medicine and Physical Fitness, 55 (9), 953-61.  Peer Reviewed verified by ORBi |
 | Rabenda, V., Bruyère, O., Cavalier, E., DEROISY, R., LECART, M.-P., COLLETTE, J., & Reginster, J.-Y. (2015). Serum concentrations of osteoprotegerin (OPG) and dickkope-1 (DKK1) poorly predict bone mineral density changes and fracture incidence in postmenopausal osteoporotic women. Osteoporosis International, 26 (S1), 240. Peer Reviewed verified by ORBi |
 | Rizzoli, R., Dawson-Hughes, B., Kaufman, J.-M., Fardellone, P., Brandi, M. L., Vellas, B., COLLETTE, J., & Reginster, J.-Y. (2014). Correction of vitamin D insufficiency with combined strontium ranelate and vitamin D3 in osteoporotic patients. European Journal of Endocrinology, 170 (3), 441-50. doi:10.1530/EJE-13-0775 Peer Reviewed verified by ORBi |
 | Lotz, M., Martel-Pelletier, J., Christiansen, C., Brandi, M.-L., Bruyère, O., Chapurlat, R., Collette, J., Cooper, C., Giacovelli, G., Kanis, J. A., Karsdal, M. A., Kraus, V., Lems, W. F., Meulenbelt, I., Pelletier, J.-P., Raynauld, J.-P., Reiter-Niesert, S., Rizzoli, R., Sandell, L. J., ... Reginster, J.-Y. (2014). Republished: Value of biomarkers in osteoarthritis: current status and perspectives. Postgraduate Medical Journal, 90 (1061), 171-8. Peer Reviewed verified by ORBi |
 | Kaux, J.-F., Croisier, J.-L., Bruyère, O., Rodriguez de la Cruz, C., DANIEL, C., GODON, B., SIMONI, P., ALVAREZ MIEZENTSEVA, V., BRABANT, G., Lapraille, S., Lonneux, V., Noël, D., COLLETTE, J., LE GOFF, C., Gothot, A., & Crielaard, J.-M. (July 2013). Platelet-rich plasma (PRP) to treat chronic upper patellar tendinopathies. British Journal of Sports Medicine, 47 (10 (e3)), 15. doi:10.1136/bjsports-2013-092558.15 Peer Reviewed verified by ORBi |
 | Kaux, J.-F., Croisier, J.-L., SIMONI, P., ALVAREZ MIEZENTSEVA, V., BRABANT, G., Lapraille, S., Lonneux, V., Noël, D., Rodriguez de la Cruz, C., COLLETTE, J., LE GOFF, C., Gothot, A., & Crielaard, J.-M. (2013). Platelet-rich plasma (PRP) to treat upper patellar tendinopathies. In Book of abstracts of 18th Annual Congress of the ECSS (pp. 744-745). ECSS. Peer reviewed |
 | Lotz, M., Martel-Pelletier, J., Christiansen, C., Berenbaum, F., Brandi, M. L., Bruyère, O., Chapurlat, R., COLLETTE, J., Cooper, C., Heinegard, D., Kanis, J. A., Kraus, V., Laslop, A., Lems, W., Lohmander, S., Meulenbelt, I., Pelletier, J.-P., Raynauld, J.-P., Reiter, S., ... Reginster, J.-Y. (April 2013). What is the value of biomarkers for drug development in osteoarthritis? Osteoporosis International, 24 (Suppl.1), 77-78. Peer Reviewed verified by ORBi |
 | Devogelaer, J.-P., Sambrook, P., Reid, D. M., Goemaere, S., Ish-Shalom, S., COLLETTE, J., Su, G., Bucci-Rechtweg, C., Papanastasiou, P., & Reginster, J.-Y. (06 March 2013). Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids. Rheumatology, 52 (6), 1058-69. doi:10.1093/rheumatology/kes410 Peer Reviewed verified by ORBi |
 | Lotz, M., Martel-Pelletier, J., Christiansen, C., Brandi, M.-L., Bruyère, O., Chapurlat, R., Collette, J., Cooper, C., Giacovelli, G., Kanis, J. A., Karsdal, M. A., Kraus, V., Lems, W. F., Meulenbelt, I., Pelletier, J.-P., Raynauld, J.-P., Reiter-Niesert, S., Rizzoli, R., Sandell, L. J., ... REGINSTER, J.-Y. (2013). Value of biomarkers in osteoarthritis: current status and perspectives. Annals of the Rheumatic Diseases, 72, 1756-1763. doi:10.1136/annrheumdis-2013-203726 Peer Reviewed verified by ORBi |
 | Lapauw, B., Vandewalle, S., Taes, Y., Goemaere, S., Zmierczak, H., COLLETTE, J., & Kaufman, J. M. (2013). Serum sclerostin levels in men with idiopathic osteoporosis. European Journal of Endocrinology, 168 (4), 615-620. doi:10.1530/EJE-12-1074 Peer Reviewed verified by ORBi |
  | Kaux, J.-F., Croisier, J.-L., Rodriguez de la Cruz, C., Lapraille, S., Lonneux, V., Noël, D., Brabant, G., DANIEL, C., LE GOFF, C., Gothot, A., Collette, J., ALVAREZ MIEZENTSEVA, V., SIMONI, P., & Crielaard, J.-M. (2012). Une infiltration de plasma riche en plaquettes (PRP) améliore les symptômes des tendinopathies patellaires supérieures. In 5ème Congrès Commun SFMES & SFTS (pp. 96). Peer reviewed |
 | Kaux, J.-F., Croisier, J.-L., SIMONI, P., Brabant, G., Lapraille, S., Lonneux, V., Noël, D., Rodriguez de la Cruz, C., Collette, J., LE GOFF, C., Gothot, A., & Crielaard, J.-M. (September 2012). Platelet-rich plasma (PRP) to treat patellar tendinopathy: preliminary results. Regional Anesthesia and Pain Medicine, 37 (5 - Suppl 1), 216. Peer Reviewed verified by ORBi |
 | Kaux, J.-F., Croisier, J.-L., SIMONI, P., Brabant, G., Lapraille, S., Lonneux, V., Noël, D., Rodriguez de la Cruz, C., Collette, J., LE GOFF, C., Gothot, A., & Crielaard, J.-M. (2012). Platelet-rich plasma (PRP) to treat upper patellar tendinopathies. In R. Meeusen, J. Duchateau, B. Roelands, M. Klass, B. De Geus, S. Baudry, ... E. Tsolakidis (Eds.), Book of Abstracts of the 17th annual Congress of the ECSS (pp. 273). ECSS. Peer reviewed |
 | Rizzoli, R., Dawson-Hughes, B., Kaufman, J., Fardellone, P., Brandi, M., Vellas, B., COLLETTE, J., & Reginster, J.-Y. (May 2012). Efficacy of a strontium ranelate 2 G/vitamin D3 1000 UI combination on the correction of vitamin D insufficiency. Osteoporosis International, 23 (S2), 225. Peer Reviewed verified by ORBi |
 | Kaux, J.-F., CROISIER, J.-L., SIMONI, P., Lonneux, V., Lapraille, S., Brabant, G., Noël, D., Rodriguez de la Cruz, C., DANIEL, C., COLLETTE, J., Gothot, A., LE GOFF, C., & Crielaard, J.-M. (2012). Platelet-rich plasma to treat jumper’s knee: preliminary results. In Biomedica 2012 (pp. 181). Peer reviewed |
 | COLLETTE, J., & Reginster, J.-Y. (March 2012). Strontium ranelate uncouples bone formation from bone resorption in male osteoporotic patients. Osteoporosis International, 23 (S2), 365-366. Peer Reviewed verified by ORBi |
 | Collette, J., Bruyère, O., & Reginster, J.-Y. (2012). Strontium ranelate decreases the level of urinary CTX-II in patients with knee osteoarthritis. Arthritis and Rheumatism, 64 (S10), 111. Peer Reviewed verified by ORBi |
 | Wampers, M., Hanssens, L., van Winkel, R., Heald, A., Collette, J., Peuskens, J., Reginster, J.-Y., SCHEEN, A., & De Hert, M. (2012). Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: Results from a 3-month prospective open-label study. European Neuropsychopharmacology, 22, 17-26. doi:10.1016/j.euroneuro.2011.03.010 Peer Reviewed verified by ORBi |
 | Rizzoli, R., Dawson-Hughes, B., Kaufman, J., Fardellone, P., Brandi, M., Vellas, B., Collette, J., & Reginster, J.-Y. (2012). Correction of vitamin D insufficiency with the fixed daily combination strontium ranelate 2 g/vitamin D3 1000 IU over 12 months. Arthritis and Rheumatism, 64 (S10), 835. Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Bruyère, O., & COLLETTE, J. (2012). Strontium ranelate treatment increases osteoprotegerin serum levels in postmenopausal osteoporotic women [letter to the editor]. BONE, 50, 1201-2. doi:10.1016/j.bone.2011.12.024 Peer Reviewed verified by ORBi |
 | Kaux, J.-F., Croisier, J.-L., SIMONI, P., Lonneux, V., Laparaille, S., Brabant, G., Noël, D., Rodriguez de la Cruz, C., DANIEL, C., COLLETTE, J., Gothot, A., LE GOFF, C., & Crielaard, J.-M. (2011). Infiltration de concentré plaquettaire dans le traitement des tendinopathies rotuliennes : résultats préliminaires. In 4ème Congrès commun SFMS & SFTS (pp. 102). Peer reviewed |
 | Bruyère, O., Collette, J., & Reginster, J.-Y. (November 2010). Effet à long terme du ranélate de strontium sur le taux sérique de propeptide C-terminal du collagène de type I (PICP) et sur le taux urinaire de télopeptide N-terminal du collagène de type I (U-NTX) chez des femmes ménopausées atteintes d’ostéoporose. Revue du Rhumatisme, 77 (Suppl.3), 183. Peer Reviewed verified by ORBi |
 | Collette, J., Bruyère, O., & Reginster, J.-Y. (November 2010). Effet du ranélate de strontium sur le taux d’ostéoprotégérine sérique chez des femmes ménopausées ostéoporotiques traitées pendant 3 ans. Revue du Rhumatisme, 77 (Suppl.3), 184. Peer Reviewed verified by ORBi |
 | Bruyère, O., Collette, J., & Reginster, J.-Y. (June 2010). Long-term effect of strontium ranelate on serum C-terminal propeptide of type I Procollagen (PICP) and urine cross-linked N-telopeptide (U-NTX) in women with postmenopausal osteoporosis. Annals of the Rheumatic Diseases, 69 (Suppl.3), 602. Peer Reviewed verified by ORBi |
 | Collette, J., Bruyère, O., Vanoverberghe, M., & Reginster, J.-Y. (June 2010). Effect of strontium ranelate on serum osteoprotegerin in women with postmenopausal osteoporosis treated over three years. Annals of the Rheumatic Diseases, 69 (Suppl.3), 602. Peer Reviewed verified by ORBi |
 | Bruyère, O., Cavalier, E., Collette, J., & Reginster, J.-Y. (2010). La vitamine D en association avec le calcium dans le traitement de l’ostéoporose. Ortho-Rhumato, 8, 53-55. |
 | Collette, J., Bruyère, O., Vanoverberghe, M., & Reginster, J.-Y. (2010). Effect of strontium ranelate on serum osteoprotegerin in women with postmenopausal osteoporosis treated over three years. Osteoporosis International, 21 (Suppl.1), 311-312. Peer Reviewed verified by ORBi |
 | Collette, J., Bruyère, O., Kaufman, J. M., Lorenc, R., Felsenberg, D., Spector, T. D., Diaz-Curiel, M., Boonen, S., & Reginster, J.-Y. (2010). Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover. Osteoporosis International, 21 (2), 233-41. doi:10.1007/s00198-009-0940-z Peer Reviewed verified by ORBi |
 | Bruyère, O., Collette, J., & Reginster, J.-Y. (2010). The effects of strontium ranelate on biochemical markers of bone turnover and their relationship with bone mineral density: reply to Stepan et al. Osteoporosis International, 21, 1039-1040. doi:10.1007/s00198-009-1156-y Peer Reviewed verified by ORBi |
 | Scheen, A., Hanssens, L., Wampers, M., Van Winkel, R., Collette, J., Reginster, J.-Y., & de Hert, M. A. (2010). Effets contrastés de l’olanzapine et de la rispéridone sur les taux plasmatiques d’adiponectine chez les patients schizophrènes nouvellement traités. In Diabetes and Metabolism (pp. 21, O78). Elsevier. Peer reviewed |
 | Bruyère, O., Collette, J., & Reginster, J.-Y. (2010). Long-term effect of strontium ranealte on serum C-terminal propeptide of type I procollagen (PICP) and urine cross-linked N-telopeptide (U-NTX) in women with postmenopausal osteoporosis. Osteoporosis International, 21 (Suppl.1), 312. Peer Reviewed verified by ORBi |
 | Bruyère, O., Collette, J., Rizzoli, R., Decock, C., Ortolani, S., Cormier, C., Detilleux, J., & Reginster, J.-Y. (2010). Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years. Osteoporosis International, 21, 1031-1036. doi:10.1007/s00198-009-1078-8 Peer Reviewed verified by ORBi |
 | Bruyère, O., COLLETTE, J., DEROISY, R., Rabenda, V., Neuprez, A., Hiligsmann, M., & Reginster, J.-Y. (October 2009). Biochemical markers of bone and cartilage remodelling: interest in the prediction of lumbar disc degeneration progression and effects of strontium ranelate over a 3-year period. Arthritis and Rheumatism, 60 (number 10 (suppl.)), 313. Peer Reviewed verified by ORBi |
 | Bruyère, O., Collette, J., Deroisy, R., Rabenda, V., Hiligsmann, M., & Reginster, J.-Y. (March 2009). Prediction of spinal osteoarthritis progression by assessment of biochemical markers of bone and cartilage remodelling: a 3-year study. Osteoporosis International, 20 (Suppl.1), 8. Peer Reviewed verified by ORBi |
 | Bruyère, O., Decock, C., Collette, J., Ortolani, S., Cormier, C., Detilleux, J., Frankinet, P., & Reginster, J.-Y. (March 2009). Relationship between 3-month changes in biochemical markers of bone remodelling and 3-year changes in bone mineral density in patients treated with strontium ranelate. Osteoporosis International, 20 (Suppl.1), 86-87. Peer Reviewed verified by ORBi |
 | Mistretta, V., Cavalier, E., Collette, J., Lutteri, L., & Chapelle, J.-P. (2009). Intérêt des anticorps monoclonaux dans le laboratoire d'analyses biomédicales. Revue Médicale de Liège, 64 (5-6), 257-263. Peer reviewed |
 | Mistretta, V., Cavalier, E., Collette, J., & Chapelle, J.-P. (2009). Production des anticorps monoclonaux. Revue Médicale de Liège, 64 (5-6), 248-252. Peer reviewed |
 | Meunier, P., Roux, C., Ortolani, S., Diaz-Curiel, M., Compston, J., Marquis, P., Cormier, C., Isaia, G., Badurski, J., Wark, J. D., Collette, J., & Reginster, J.-Y. (2009). Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis. Osteoporosis International, 20, 1663-73. doi:10.1007/s00198-008-0825-6 Peer Reviewed verified by ORBi |
 | Bruyère, O., Decock, C., Delhez, M., Collette, J., & Reginster, J.-Y. (2009). Highest prevalence of vitamin D inadequacy in institutionalized women compared with noninstitutionalized women: a case-control study. Women's Health, 5 (1), 49-54. doi:10.2217/17455057.5.1.49 Peer Reviewed verified by ORBi |
 | Scholtissen, S., Guillemin, F., Bruyère, O., Collette, J., Dousset, B., Kemmer, C., Culot, S., Cremer, D., Dejardin, H., Hubermont, G., Lefebvre, D., Pascal-Vigneron, V., Weryha, G., & Reginster, J.-Y. (2009). Assessment of determinants for osteoporosis in elderly men. Osteoporosis International, 20 (7), 1157-66. doi:10.1007/s00198-008-0789-6 Peer Reviewed verified by ORBi |
 | Cavalier, E., Delanaye, P., Carlisi, I., Chapelle, J.-P., & Collette, J. (2009). An unusual interference in parathormone assay caused by anti-goat IgG: a case report. Clinical Chemistry and Laboratory Medicine, 47 (1), 118. doi:10.1515/CCLM.2009.015 Peer Reviewed verified by ORBi |
 | Bruyère, O., Decock, C., COLLETTE, J., Ortolani, S., Cormier, C., Detilleux, J., FRANKINET, P., & Reginster, J.-Y. (October 2008). Relationship between 3-month changes in biochemical markers of bone remodelling and 3-year changes in bone mineral density in patients treated with strontium ranelate. Arthritis and Rheumatism, 58 (Suppl.1), 743. Peer Reviewed verified by ORBi |
 | DeCock, C., Bruyère, O., Collette, J., & Reginster, J.-Y. (July 2008). Déficit en vitamine D chez les femmes françaises ostéoporotiques et ostéopéniques. Revue du Rhumatisme, 75, 839-844. doi:10.1016/j.rhum.2007.10.623 Peer Reviewed verified by ORBi |
 | Bruyère, O., Delhez, M., Collette, J., & Reginster, J.-Y. (June 2008). Prevalence of vitamin D inadequacy in institutionalized osteoporotic postmenopausal women. Annals of the Rheumatic Diseases, 67 (Suppl.II), 403. Peer Reviewed verified by ORBi |
 | Bruyère, O., Collette, J., Christiansen, F., Fardellone, F., Detroz, A., Deroisy, R., & Reginster, J.-Y. (June 2008). Association between lumbar disc degeneration and biochemical markers of bone and cartilage remodelling. Annals of the Rheumatic Diseases, 67 (Suppl.II), 231. Peer Reviewed verified by ORBi |
 | Saag, K. G., Devogelaer, J.-P., Reid, D. M., Sambrook, P., Goemaere, S., Ish-Shalom, S., Collette, J., Papanastasiou, P., Ferreira, A., Eriksen, E. F., Fashola, T., Schoenborn-Kellenberger, O., Chappard, D., & Reginster, J.-Y. (June 2008). Effects of a single 5 mg infusion of zoledronic acid and oral risedronate (5 mg/day) on bone remodeling over one year in patients with glucocorticoid-induced osteoporosis. Annals of the Rheumatic Diseases, 67 (Suppl.II), 542. Peer Reviewed verified by ORBi |
 | Bruyère, O., Collette, J., Christiansen, C., Padrino, J. M., Fardellone, J. P., Detroz, A., Deroisy, R., & Reginster, J.-Y. (April 2008). Association between spinal osteoarthritis and biochemical markers of bone and cartilage remodelling. Osteoporosis International, 19 (Suppl.1), 200. Peer Reviewed verified by ORBi |
 | Collette, J., Reginster, J.-Y., Zerbini, C., Neate, C., Sederati, F., & Delmas, P. D. (April 2008). Reduction in bone remodelling markers with monthly oral ibandronate (150 mg) and weekly alendronate (70 mg): results from the motion study. Osteoporosis International, 19 (Suppl.1), 207. Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Collette, J., NEUPREZ, A., Zegels, B., Deroisy, R., & Bruyère, O. (10 February 2008). Role of Biochemical Markers of Bone Turnover as Prognostic Indicator of Successful Osteoporosis Therapy. BONE, 42, 832-836. doi:10.1016/j.bone.2008.01.021 Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Collette, J., Neuprez, A., & Bruyère, O. (2008). Strontium ranelate in the management of spinal and peripheral osteoporosis. Review of Endocrinology, 26-33. Peer reviewed |
 | Bruyère, O., Decock, C., Collette, J., Ortolani, S., Cormier, C., Detilleux, J., Franquinet, P., & Reginster, J.-Y. (2008). Relationship between 3-month changes in biochemical markers of bone remodelling and 3-year changes in bone mineral density in patients treated with strontium ranelate. Osteoporosis International, 19 (S2), 244. Peer Reviewed verified by ORBi |
 | De Cock, C., Bruyère, O., Collette, J., & Reginster, J.-Y. (2008). Vitamin D inadequacy in French osteoporotic and osteopenic women. Joint Bone Spine, 75 (5), 567-72. doi:10.1016/j.jbspin.2007.10.012 Peer Reviewed verified by ORBi |
 | Hanssens, L., van Winkel, R., Wampers, M., Van Eyck, D., Scheen, A., Reginster, J.-Y., Collette, J., Peuskens, J., & De Hert, M. (2008). A cross-sectional evaluation of adiponectin plasma levels in patients with schizophrenia and schizoaffective disorder. Schizophrenia Research, 106 (2-3), 308-14. doi:10.1016/j.schres.2008.09.008 Peer Reviewed verified by ORBi |
 | Chappard, D., Saag, K., Devogelaer, J., Reid, D., Sambrook, P., Goemaere, S., COLLETTE, J., Ish-Shalom, S., Papanastasiou, P., Ferreira, A., Eriksen, E., Schoenborn-Kellenberger, O., & Reginster, J.-Y. (2008). Effets d'une perfusion unique d'acide zolédronique 5 mg versus risédronate (5 mg/jour) sur le remodelage osseux sur 1 an chez des patients avec ostéroporose cortisonique. Revue du Rhumatisme, 75, 1036. Peer Reviewed verified by ORBi |
 | Bruyère, O., Malaise, O., NEUPREZ, A., Collette, J., & Reginster, J.-Y. (August 2007). Prevalence of vitamin D inadequacy in European postmenopausal women. Current Medical Research and Opinion, 23 (8), 1939-1944. doi:10.1185/030079907X219562 Peer Reviewed verified by ORBi |
 | COLLETTE, J., Reginster, J.-Y., Bruyère, O., Roux, C., Lorenc, R., Felsenberg, D., & Spector, T. D. (May 2007). Strontium ranelate decreases vertebral fracture risk whatever the level of pretreatment bone turnover markers. Calcified Tissue International, 80 (Suppl.1), 29-30. Peer Reviewed verified by ORBi |
 | COLLETTE, J., Reginster, J.-Y., Bruyère, O., DEROISY, R., Jupsin, I., Devogelaer, J.-P., Adami, S., & Marcelli, C. (May 2007). Dissociation between bone formation and bone resorption evidenced by changes in biochemical markers of bone turnover in patients treated with strontium ranelate. Calcified Tissue International, 80 (Suppl.1), 120. Peer Reviewed verified by ORBi |
 | Neuprez, A., Bruyère, O., Collette, J., & Reginster, J.-Y. (26 April 2007). Vitamin D inadequacy in Belgian postmenopausal osteoporotic women. BMC Public Health, 7 (147), 64. doi:10.1186/1471-2458-7-64 Peer Reviewed verified by ORBi |
 | Bruyère, O., MALAISE, O., Neuprez, A., Collette, J., & Reginster, J.-Y. (March 2007). Prevalence of vitamin D inadequacy is high in European postmenopausal women. Osteoporosis International, 18 (Suppl.1), 124. Peer Reviewed verified by ORBi |
 | Collette, J., Reginster, J.-Y., Bruyère, O., Roux, C., Lorenc, R., Felsenberg, D., & Spector, T. D. (March 2007). Strontium ranelate decreases vertebral fracture risk whatever the level of pretreatment bone turnover markers. Osteoporosis International, 18 (Suppl.1), 127-128. Peer Reviewed verified by ORBi |
 | Collette, J., Reginster, J.-Y., Bruyère, O., Deroisy, R., Jupsin, I., Devogelaer, J.-P., Adami, S., & Marcelli, C. (March 2007). Dissociation between bone formation and bone resorption evidenced by changes in biochemical markers of bone turnover in patients treated with strontium ranelate. Osteoporosis International, 18 (Suppl.1), 125. Peer Reviewed verified by ORBi |
 | Bruyère, O., MALAISE, O., Neuprez, A., Collette, J., & Reginster, J.-Y. (December 2006). Prévalence élevée de la carence en vitamine D chez la femme ménopausée en Europe et principalement en France : analyse d'une cohorte de 8532 sujets. Revue du Rhumatisme, 73, 1052. Peer Reviewed verified by ORBi |
 | Bruyère, O., MALAISE, O., Neuprez, A., COLLETTE, J., & Reginster, J.-Y. (November 2006). European postmenopausal osteoporotic women have high prevalence of vitamin D inadequacy. Arthritis and Rheumatism, 54 (Suppl), 585. Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., COLLETTE, J., Bruyère, O., DEROISY, R., & Jupsin, I. (November 2006). Biochemical markers of bone turnover confirm the dual mode of action of strontium ranelate: increase in bone formation and decrease in bone resorption. Arthritis and Rheumatism, 54 (Suppl), 590. Peer Reviewed verified by ORBi |
 | Cavalier, E., Delanaye, P., Collette, J., Krzesinski, J.-M., & Chapelle, J.-P. (September 2006). Evaluation of different bone markers in hemodialyzed patients. Clinica Chimica Acta, 371 (1-2), 107-111. doi:10.1016/j.cca.2006.02.029 Peer Reviewed verified by ORBi |
 | Bruyère, O., Collette, J., Kothari, M., Zaim, S., White, D., Genant, H., Peterfy, C., Burlet, N., Ethgen, D., Montague, T., Dabrowski, C., & Reginster, J.-Y. (August 2006). Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study. Annals of the Rheumatic Diseases, 65 (8), 1050-1054. doi:10.1136/ard.2005.045914 Peer Reviewed verified by ORBi |
 | Manette, C., Collette, J., Sarlet, N., Tancredi, A., Zegels, B., & Reginster, J.-Y. (2006). Comprehensive therapy in osteoporosis using a single drug: From ADFR to strontium ranelate. Current Medicinal Chemistry, 13 (13), 1585-1590. doi:10.2174/092986706777442057 Peer Reviewed verified by ORBi |
 | Le Goff, C., Wiesen, P., Collette, J., Preiser, J.-C., Kaux, J.-F., & De Mol, P. (27 October 2005). Pseudomembranous colitis with Clostridium difficile during treatment by moxifloxacine (quinolone) [Poster presentation]. Symposium Annuel de la Société Belge de Biologie Clinique (S.B.B.C.), Liège, Belgium. |
 | Kothari, M., Bruyère, O., COLLETTE, J., Peterfy, C., Zaim, S., White, D., Burlet, N., Ethgen, D. J., Montague, T., Dabrowski, C., Reginster, J.-Y., & Genant, H. K. (September 2005). Magnetic Resonance Imaging and biochemical markers of osteoarthritis of the knee. Arthritis and Rheumatism, 52 (number 9 (suppl.)), 71. Peer Reviewed verified by ORBi |
 | Jupsin, I., Collette, J., Henrotin, Y., Bruyère, O., Sarlet, N., & Reginster, J.-Y. (April 2005). Strontium Ranelate (Fujisawa/Servier). Current Opinion in Investigational Drugs, 6 (4), 435-44. Peer Reviewed verified by ORBi |
 | Bruyère, O., COLLETTE, J., Kothari, M., Zaim, S., White, D., Peterfy, C., Burlet, N., Ethgen, D., Montague, T., & Reginster, J.-Y. (March 2005). Baseline hyaluronic acid measurement predicts one-year changes in knee magnetic resonance imaging global score (WORMS) in patients with knee osteoarthritis. Osteoporosis International, 16 (Suppl.3), 47. Peer Reviewed verified by ORBi |
 | Deberg, M., Labasse, A., Collette, J., Seidel, L., Reginster, J.-Y., & Henrotin, Y. (2005). One-year increase of Coll 2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression. Osteoarthritis and Cartilage, 13 (12), 1059-65. doi:10.1016/j.joca.2005.06.014 Peer Reviewed verified by ORBi |
 | Franchimont, N., Putzeys, V., Collette, J., Vermeire, S., Rutgeerts, P., De Vos, M., Van Gossum, A., Franchimont, D., Fiasse, R., Pelckmans, P., Malaise, M., Belaiche, J., & Louis, E. (15 September 2004). Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease. Alimentary Pharmacology and Therapeutics, 20 (6), 607-614. doi:10.1111/j.1365-2036.2004.02152.x Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Sarkar, S., Zegels, B., Henrotin, Y., Bruyère, O., Agnusdei, D., & Collette, J. (February 2004). Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk. BONE, 34 (2), 344-351. doi:10.1016/j.bone.2003.10.004 Peer Reviewed verified by ORBi |
 | Christgau, S., Henrotin, Y., Tanko, L. B., Rovati, L. C., Collette, J., Bruyère, O., Deroisy, R., & Reginster, J.-Y. (2004). Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate. Clinical and Experimental Rheumatology, 22 (1, JAN-FEB), 36-42. Peer Reviewed verified by ORBi |
 | Christin-Maitre, S., Laveille, C., Collette, J., Brion, N., & Reginster, J.-Y. (01 November 2003). Pharmacodynamics of follicle stimulating hormone (FSH) in postmenopausal women during pulsed estrogen therapy: Evidence that FSH release and synthesis are controlled by distinct pathways. Journal of Clinical Endocrinology and Metabolism, 88 (11), 5405-5413. doi:10.1210/jc.2003-030094 Peer Reviewed verified by ORBi |
 | Xu, L., Liu, J., Lin, J., Wang, S., Wu, Y., Huang, Q., Boudes, P., Korner, P., Tegtmeier, J., Xiaoxiang, C., Collette, J., & Reginster, J.-Y. (November 2003). Effects of bazedoxifene (TSE-424), a novel tissue selective estrogen receptor modulator (SERM), on biochemical markers of bone metabolism in a chinese population. Osteoporosis International, 14 (Suppl. 7), 97-98. Peer Reviewed verified by ORBi |
 | Henrotin, Y., Deberg, M., Labasse, A., Collette, J., Christgau, S., Henriksen, D. B., Seidel, L., Rovati, L. C., & Reginster, J.-Y. (November 2003). One-year increase of Coll 2-1 level in urine is predictive of OA progression. Osteoporosis International, 14 (Suppl. 7), 12. Peer Reviewed verified by ORBi |
 | Bruyère, O., COLLETTE, J., Ethgen, O., Rovati, L. C., Giacovelli, G., Henrotin, Y., Seidel, L., & Reginster, J.-Y. (May 2003). Biochemical markers of bone and cartilage remodeling in prediction of longterm progression of knee osteoarthritis. Journal of Rheumatology, 30 (5), 1043-50. Peer Reviewed verified by ORBi |
 | Collette, J., Viethel, P., Dethor, M., Chevallier, T., Micheletti, M. C., Foidart, J.-M., & Reginster, J.-Y. (May 2003). Comparaison de l'evolution des marqueurs biologiques du remodelage osseux apres six mois de traitement hormonal substitutif par 17 beta-estradiol cutane ou estrogenes sulfoconjugues equins et acetate de nomegestrol. Gynécologie Obstétrique et Fertilité, 31 (5), 434-41. doi:10.1016/S1297-9589(03)00118-8 Peer Reviewed verified by ORBi |
 | Bruyère, O., Collette, J., Delmas, P., Rouillon, A., Roux, C., Seidel, L., Richy, F., & Reginster, J.-Y. (25 April 2003). Interest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic women. Maturitas, 44 (4), 259-265. doi:10.1016/S0378-5122(03)00042-2 Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Deroisy, R., Dougados, M., Jupsin, I., Collette, J., & Roux, C. (December 2002). Prevention of early postmenopausal bone loss by strontium ranelate: The randomized, two-year, double-masked, dose-ranging, placebo-controlled PREVOS trial. Osteoporosis International, 13 (12), 925-931. doi:10.1007/s001980200129 Peer Reviewed verified by ORBi |
 | Bruyère, O., Collette, J., Lejeune, E., Ethgen, O., Richy, F., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (November 2002). Correlation between biochemical markers of bone and cartilage metabolism and structural progression of hand osteoarthritis. A three-year prospective study. Osteoporosis International, 13 (Suppl.3), 51. Peer Reviewed verified by ORBi |
 | Bruyère, O., Collette, J., Lejeune, E., Ethgen, O., Richy, F., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (November 2002). Baseline measurement of urine pyridinoline and deoxypyridinoline is correlated with 3-year hip osteoarthritis progression. Osteoporosis International, 13 (Suppl.3), 51. Peer Reviewed verified by ORBi |
 | Deberg, M., Christgau, S., Henriksen, D., Cloos, P., COLLETTE, J., Reginster, J.-Y., & Henrotin, Y. (September 2002). Development of new immunoassays for the quantification of inflammatory related cartilage degradation. Arthritis and Rheumatism, 46 (number 9 (suppl.)), 496. Peer Reviewed verified by ORBi |
 | Bruyère, O., COLLETTE, J., Lejeune, E., Ethgen, O., Richy, F., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (September 2002). Correlation between biochemical markers of bone and cartilage metabolism and structural progression of hand osteoarthritis. A three year prospective study. Arthritis and Rheumatism, 46 (number 9 (suppl.)), 152-3. Peer Reviewed verified by ORBi |
 | Bruyère, O., COLLETTE, J., Lejeune, E., Richy, F., Ethgen, O., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (September 2002). Baseline measurement of urine pyridinoline and deoxypyridinoline is correlated with 3-year hip osteoarthritis progression. Arthritis and Rheumatism, 46 (number 9 (suppl.)), 149. Peer Reviewed verified by ORBi |
 | Deroisy, R., Collette, J., Albert, A., Jupsin, I., & Reginster, J.-Y. (February 2002). Administration of a supplement containing both calcium and vitamin D is more effective than calcium alone to reduce secondary hyperparathyroidism in postmenopausal women with low 25(OH)vitamin D circulating levels. Aging Clinical and Experimental Research, 14 (1), 13-17. doi:10.1007/BF03324412 Peer Reviewed verified by ORBi |
Reginster, J.-Y., Taquet, A. N., Christiansen, C., Gamwell-Henriksen, E., Christgau, S., Bruyère, O., & COLLETTE, J. (2001). Respective value of four biochemical markers of bone resorption for the diagnosis of postmenopausal osteoporosis and the monitoring of anti-resorptive therapies. Clinical Rheumatology, 5 (Suppl.1), 421. Peer Reviewed verified by ORBi |
Bruyère, O., COLLETTE, J., Delmas, P., Rouillon, A., Roux, C., Seidel, L., & Reginster, J.-Y. (2001). Early (3-month) changes in serum osteocalcin and urinary C-telopeptide of type I collagen could be of interest to identify postmenopausal osteoporotic women with the highest risk to present new vertebral deformities. Arthritis and Rheumatism, 44 (Suppl.1), 257. Peer Reviewed verified by ORBi |
 | Zegels, B., Eastell, R., Russell, R. G., Ethgen, D., Roumagnac, I., Collette, J., & Reginster, J.-Y. (January 2001). Effect of High Doses of Oral Risedronate (20 Mg/Day) on Serum Parathyroid Hormone Levels and Urinary Collagen Cross-Link Excretion in Postmenopausal Women with Spinal Osteoporosis. BONE, 28 (1), 108-12. doi:10.1016/S8756-3282(00)00410-5 Peer Reviewed verified by ORBi |
 | DEROISY, R., Collette, J., Albert, A., JUPSIN, I., & Reginster, J.-Y. (2001). Supplementation with a calcium-vitamin D association is more efficient than calcium alone to reduce secondary hyperparathyroidism in postmenopausal women with low 25(OH) vitamin D circulating levels. Clinical Rheumatology, 20, 424. Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Taquet, A., Christiansen, C., Gamwell-Henriksen, E., Bruyère, O., Collette, J., & Christgau, S. (2001). Bone resorption in postmenopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I. BONE, S28, 177. Peer Reviewed verified by ORBi |
 | Kecha-Kamoun, O., Achour, I., Martens, H., Collette, J., Lefebvre, P. J., Greiner, D. L., & Geenen, V. (2001). Thymic Expression of Insulin-Related Genes in an Animal Model of Autoimmune Type 1 Diabetes. Diabetes/Metabolism Research and Reviews, 17 (2, Mar-Apr), 146-52. doi:10.1002/dmrr.182 Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Henrotin, Y., Christiansen, C., Gamwell-Henriksen, E., Bruyère, O., Collette, J., & Christgau, S. (2001). Bone resorption in post-menopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I. Calcified Tissue International, 69 (3), 130-137. doi:10.1007/s002230020042 Peer Reviewed verified by ORBi |
Reginster, J.-Y., COLLETTE, J., Bruyère, O., Rovati, L. C., Giacovelli, G., DEROISY, R., Seidel, L., & Henrotin, Y. (2001). Short term (1-year) changes in keratan sulfate levels predict long-term (3-year) radiological evolution of knee osteoarthritis in patients treated with glucosamine sulfate. Osteoarthritis and Cartilage, 9 (Suppl.B), 35. Peer Reviewed verified by ORBi |
 | DEROISY, R., Collette, J., Taquet, A., Thines, F., & Reginster, J.-Y. (2001). Comparison of the effect of combined calcium-vitamin D or calcium alone administration on circulating levels of parathyroid hormone (PTH) and 25-OH vitamin D (25-OHD) in ambulatory vitamin D-depleted post-menopausal women. BONE, S28, 231. Peer Reviewed verified by ORBi |
Bruyère, O., COLLETTE, J., Delmas, P., Rouillon, A., Roux, C., Seidel, L., & Reginster, J.-Y. (2001). Early (3-month) changes in serum osteocalcin and urinary C-telopeptide of type I collagen could be of interest to identify postmenopausal osteoporotic women with the highest risk to present new vertevral deformities. Clinical Rheumatology, 5 (Suppl.1), 426. Peer Reviewed verified by ORBi |
Bruyère, O., COLLETTE, J., Delmas, P., Rouillon, A., Seidel, L., & Reginster, J.-Y. (2001). Interest of four biochemical markers of bone turnover in prediction of baseline and long-term (changes) of bone mineral density in postmenopausal osteoporotic women. Clinical Rheumatology, 5 (Suppl.1), 426. Peer Reviewed verified by ORBi |
Reginster, J.-Y., COLLETTE, J., Bruyère, O., Rovati, L. C., Giacovelli, G., DEROISY, R., Seidel, L., & Henrotin, Y. (2001). Short term (1-year) changes in keratan sulfate levels predict long-term (3-year) radiological evolution of knee osteoarthritis in patients treated with glucosamine sulfate. Arthritis and Rheumatism, 44 (Suppl.1), 139. Peer Reviewed verified by ORBi |
Reginster, J.-Y., Sakar, S., COLLETTE, J., Zegels, B., Henrotin, Y., Bruyère, O., Wrong, M., Harper, K., & Agnusdei, D. (2001). Relationship between 1-year change in bone turnover marker PINP and 3-year vertebral fracture risk reduction with raloxifene therapy in postmenopausal women with osteoporosis: result from the MORE trial. BONE, 28 (Suppl.1), 239. Peer Reviewed verified by ORBi |
Reginster, J.-Y., COLLETTE, J., Zegels, B., Henrotin, Y., Bruyère, O., & Durez, P. (2001). Relationship between 1-year change in bone turnover marker PINP and 3-year vertebral fracture risk reduction with raloxifene therapy in postmenopausal women with osteoporosis: result from the MORE trial. Clinical Rheumatology, 5 (Suppl.1), 425. Peer Reviewed verified by ORBi |
Reginster, J.-Y., Taquet, A. N., Christiansen, C., Gamwell-Henriksen, E., Bruyère, O., COLLETTE, J., & Christgau, S. (2001). Bone resorption in postmenopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I. Clinical Rheumatology, 5 (Suppl.1), 427. Peer Reviewed verified by ORBi |
 | Hajitou, A., Deroanne, C., Noël, A., Collette, J., Nusgens, B., Foidart, J.-M., & Calberg-Bacq, C. M. (March 2000). Progression in MCF-7 Breast Cancer Cell Tumorigenicity: Compared Effect of FGF-3 and FGF-4. Breast Cancer Research and Treatment, 60 (1), 15-28. doi:10.1023/A:1006302602261 Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., COLLETTE, J., Rovati, L. C., DEROISY, R., Honore, A., Bruyère, O., Seidel, L., & Henrotin, Y. (2000). Biochemical markers of bone and cartilage remodeling are poorly correlated with clinical and radiological severity of knee osteoarthritis. Arthritis and Rheumatism, 43 (Suppl.1), 339. Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., COLLETTE, J., Rovati, L. C., DEROISY, R., Bruyère, O., & Henrotin, Y. (2000). Changes in serum osteocalcin but not other serum and urinary markers of bone and cartilage metabolism, measured after 12 months, are significantly correlated to long-term (36 monts) structural changes in knee osteoarthritis. Arthritis and Rheumatism, 43 (Suppl.1), 398. Peer Reviewed verified by ORBi |
 | Bruyère, O., COLLETTE, J., Zegels, B., Rovati, L. C., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (2000). Baseline values and early (6-month) changes in total and bone specific alkaline phosphatase do not predict long-term (4-year) bone mineral density changes in postmenopausal osteoporotic women treated with fluoride. Arthritis and Rheumatism, 43 (S1), 199. Peer Reviewed verified by ORBi |
 | Christgau, S., Henrotin, Y., Enriksen, D., Rovati, L., Collette, J., DEROISY, R., Christiansen, C., & Reginster, J.-Y. (2000). Cartilage degradation in knee osteoarthritis patients with elevated levels of urinary collagen type II C-telopeptide fragments. Arthritis and Rheumatism, 43 (S1), 1243. Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Taquet, A., Christiansen, C., Gamwell-Henriksen, F., & Collette, J. (1999). Comparison of four markers of bone resorption as diagnostic or monitoring tools in postmenopausal osteoporosis. Arthritis and Rheumatism, 42 (S1), 291. Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Deroisy, R., Pirenne, H., Frederick, I., Dewé, W., Albert, A., Collette, J., Zheng, S. X., & Gosset, C. (1999). High Prevalence of Low Femoral Bone Mineral Density in Elderly Women Living in Nursing Homes or Community-Dwelling: A Plausible Role of Increased Parathyroid Hormone Secretion. Osteoporosis International, 9 (2), 121-8. doi:10.1007/s001980050124 Peer Reviewed verified by ORBi |
 | Winkler, R., Delacroix, L., Bensbaho, K., Lambert, S., Collette, J., & Hodzic, D. (1999). IGF-II in primary human colorectal tumors: peptide level, activated promoters, parental imprinting and gene rearrangement. Hormone and Metabolic Research, 31 (2-3), 148-54. doi:10.1055/s-2007-978713 Peer Reviewed verified by ORBi |
 | Hajitou, A., Baramova, E., Bajou, K., Noë, V., Bruyneel, E., Mareel, M., Collette, J., Foidart, J.-M., & Calberg-Bacq, C.-M. (22 October 1998). Fgf-3 and Fgf-4 Elicit Distinct Oncogenic Properties in Mouse Mammary Myoepithelial Cells. Oncogene, 17 (16), 2059-71. doi:10.1038/sj.onc.1202126 Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Meurmans, L., Zegels, B., Rovati, L. C., Minne, H. W., Giacovelli, G., Taquet, A. N., Setnikar, I., Collette, J., & Gosset, C. (01 July 1998). The Effect of Sodium Monofluorophosphate Plus Calcium on Vertebral Fracture Rate in Postmenopausal Women with Moderate Osteoporosis. A Randomized, Controlled Trial. Annals of Internal Medicine, 129 (1), 1-8. doi:10.7326/0003-4819-129-1-199807010-00001 Peer Reviewed verified by ORBi |
 | DEROISY, R., Collette, J., Chevalier, T., Breuil, V., & Reginster, J.-Y. (1998). Effects of two 1-year calcium and vitamin D3 treatments on bone remodeling markers and femoral bone density in elderly women. Current Therapeutic Research, 59 (12), 850-862. doi:10.1016/S0011-393X(98)85050-9 Peer Reviewed verified by ORBi |
DEROISY, R., Taquet, A., Dewe, W., Albert, A., Collette, J., Gosset, C., & Reginster, J.-Y. (1998). Parathyroid hormone plasma concentration in response to low 25-OH vitamin D circulating levels increase with age in elderly women. Osteoporosis International, 8 (S3), 40. Peer Reviewed verified by ORBi |
Deroisy, R., Collette, J., Dewe, W., Albert, A., Gosset, C., & Reginster, J.-Y. (1998). Increased parathyroïd hormone secretions as a risk factor for femoral osteoporosis in elderly women. Osteoporosis International, 8 (S3), 40. Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Frederick, I., Deroisy, R., Dewe, W., Taquet, A. N., Albert, A., Collette, J., Pirenne, H., Zheng, S. X., & Gosset, C. (1998). Parathyroid hormone plasma concentrations in response to low 25-OH vitamin D circulating levels increases with age in elderly women. Osteoporosis International, 8 (4), 390-2. doi:10.1007/s001980050080 Peer Reviewed verified by ORBi |
 | DEROISY, R., Collette, J., Albert, A., Leber, C., Micheletti, M., Zartarian, M., & Reginster, J.-Y. (1998). Comparison of the short-term effects of three oral calcium vitamin D formulations and placebo on calcium metabolism. Current Therapeutic Research, 59 (6), 370-378. doi:10.1016/S0011-393X(98)85039-X Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Albert, A., Deroisy, R., Collette, J., Vrijens, B., Blacker, C., Brion, N., Caulin, F., Mayolle, C., Regnard, A., Scholler, R., & Franchimont, P. (June 1997). Plasma Estradiol Concentrations and Pharmacokinetics Following Transdermal Application of Menorest 50 or Systen (Evorel) 50. Maturitas, 27 (2), 179-86. doi:10.1016/S0378-5122(97)00027-3 Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Deroisy, R., Collette, J., Albert, A., & Zegels, B. (March 1997). Prediction of Bone Loss Rate in Healthy Postmenopausal Women. Calcified Tissue International, 60 (3), 261-4. doi:10.1007/s002239900226 Peer Reviewed verified by ORBi |
 | Zheng, S. X., Vrindts-Gevaert, Y., Lopez, M.-J., De Groote, D., Zangerlé, P.-F., Collette, J., Franchimont, N., Geenen, V., Albert, A., & Reginster, J.-Y. (January 1997). Increase in Cytokine Production (Il-1 Beta, Il-6, Tnf-Alpha but Not Ifn-Gamma, Gm-Csf or Lif) by Stimulated Whole Blood Cells in Postmenopausal Osteoporosis. Maturitas, 26 (1), 63-71. doi:10.1016/S0378-5122(96)01080-8 Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Meurmans, L., Zegels, B., Rovati, L., Minne, H., Giacovelli, G., Taquet, A., Setnikar, I., & Collette, J. (1997). Sodium monofluorophosphate reduces vertebral fractures in moderate postmenopausal osteoporosis. Journal of Bone and Mineral Research, 12 (S1), 104. Peer Reviewed verified by ORBi |
 | Hodzic, D., Delacroix, L., Willemsen, P., Bensbaho, K., Collette, J., Broux, R., Lefebvre, P., Legros, J.-J., Grooteclaes, M., & Winkler, R. (1997). Characterization of the IGF system and analysis of the possible molecular mechanisms leading to IGF-II overexpression in a mesothelioma. Hormone and Metabolic Research, 29 (11), 549-55. doi:10.1055/s-2007-979099 Peer Reviewed verified by ORBi |
 | DEROISY, R., Zheng, X., Pirenne, H., Frederick, I., COLLETTE, J., & Reginster, J.-Y. (1996). 25-OH vitamin D deficiencies and secondary hyperparathyroidism in elderly women living at home or in nursing/retirement homes. Osteoporosis International, 6 (S1), 119. Peer Reviewed verified by ORBi |
 | Zheng, S., Geenen, V., Vrindts, Y., Lopez, M., De Groote, D., Zangerlé, P.-F., COLLETTE, J., & Reginster, J.-Y. (1996). Increase in IL-1bêta, IL-6, and TNF-alpha production in postmenopausal osteoporosis. Osteoporosis International, 6 (S1), 101. Peer Reviewed verified by ORBi |
 | Biquet, I., COLLETTE, J., Dauphin, J., Albert, A., Thunus, L., Deby-Dupont, G., & Reginster, J.-Y. (1996). Prevention of postmenopausal bone loss by administration of boron. Osteoporosis International, 6 (S1), 249. Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Zegels, B., Meurmans, L., Rovati, L., Taquet, A., Setnikar, I., & COLLETTE, J. (1996). Monofluorophosphate decreases vertebral fracture rate in postmenopausal osteoporosis: a randomised, placebo-controlled, double blind study. Osteoporosis International, 6 (S1), 239. Peer Reviewed verified by ORBi |
 | DEROISY, R., Albert, A., Zheng, S., COLLETTE, J., & Reginster, J.-Y. (1996). 25-OH vitamin D levels in healthy ambulatory postmenopausal women. Osteoporosis International, 6 (S1), 119. Peer Reviewed verified by ORBi |
Hans, P., Bonhomme, V., Collette, J., Albert, A., & Moonen, G. (October 1994). Propofol Protects Cultured Rat Hippocampal Neurons against N-Methyl-D-Aspartate Receptor-Mediated Glutamate Toxicity. Journal of Neurosurgical Anesthesiology, 6 (4), 249-53. doi:10.1097/00008506-199410000-00004 Peer Reviewed verified by ORBi |
 | Bonhomme, V., Hans, P., Collette, J., & Moonen, G. (April 1993). Neuron-Specific Enolase as a Marker of in Vitro Neuronal Damage. Part II: Investigation of the Astrocyte Protective Effect against Kainate-Induced Neurotoxicity. Journal of Neurosurgical Anesthesiology, 5 (2), 117-20. doi:10.1097/00008506-199304000-00008 Peer Reviewed verified by ORBi |
 | Hans, P., Bonhomme, V., Collette, J., & Moonen, G. (April 1993). Neuron-Specific Enolase as a Marker of in Vitro Neuronal Damage. Part I: Assessment of Neuron-Specific Enolase as a Quantitative and Specific Marker of Neuronal Damage. Journal of Neurosurgical Anesthesiology, 5 (2), 111-6. doi:10.1097/00008506-199304000-00007 Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Meurmans, L., Zegels, B., Darte, C., COLLETTE, J., DEROISY, R., & Franchimont, P. (1993). New radioimmunoassay for determination of bone specific iso-enzymes of serum alkaline phosphatases activity (Ostase°): validation and clinical perspective. Journal of Bone and Mineral Research, 8 (S1), 261. Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Denis, D., Deroisy, R., Albert, A., Sarlet, N., Collette, J., & Franchimont, P. (June 1990). Dual Photon Absorptiometry of Lumbar Spine in West European (Belgian) Postmenopausal Females: Normal Range and Fracture Threshold. Clinical Rheumatology, 9 (2), 220-4. doi:10.1007/BF02031972 Peer Reviewed verified by ORBi |
Reginster, J.-Y., Lecart, M., DEROISY, R., SARLET, N., Denis, D., Albert, A., COLLETTE, J., & Franchimont, P. (1990). Prevention of postmenopausal bone loss by tiludronate. Menopause Digest, 4, 28. Peer reviewed |
 | Reginster, J.-Y., Gennari, C., Mautalen, C., Deroisy, R., Denis, D., Lecart, M. P., Vandalem, J. L., Collette, J., & Franchimont, P. (1990). Influence of Specific Anti-Salmon Calcitonin Antibodies on Biological Effectiveness of Nasal Salmon Calcitonin in Paget's Disease of Bone. Scandinavian Journal of Rheumatology, 19 (1), 83-6. doi:10.3109/03009749009092626 Peer Reviewed verified by ORBi |
 | Henrotin, Y., Bassleer, C., Collette, J., Nusgens, B., & Franchimont, P. (1990). Radioimmunoassay for Human Type Ii Collagen. Journal of Immunoassay, 11 (4), 555-578. doi:10.1080/01971529008055050 Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Deroisy, R., Albert, A., Denis, D., Lecart, M.-P., Collette, J., & Franchimont, P. (March 1989). Relationship between Whole Plasma Calcitonin Levels, Calcitonin Secretory Capacity, and Plasma Levels of Estrone in Healthy Women and Postmenopausal Osteoporotics. Journal of Clinical Investigation, 83 (3), 1073-7. doi:10.1172/JCI113950 Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Lecart, M. P., Deroisy, R., Sarlet, N., Denis, D., Ethgen, D., Collette, J., & Franchimont, P. (1989). Prevention of Postmenopausal Bone Loss by Tiludronate. The Lancet, 2 (8678-8679, Dec 23-30), 1469-71. doi:10.1016/S0140-6736(89)92927-9 Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Lecart, M., DEROISY, R., Sarlet, N., Denis, D., Albert, A., COLLETTE, J., & Franchimont, P. (1989). Prevention of postmenopausal bone loss by intermittent oral bisphosphonate: Chloro-4-phenyl thiomethylene bisphosphonate: a one year double-blind study. Journal of Bone and Mineral Research, 4 (S1), 214. Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., JEUGMANS, A.-M., Albert, A., Denis, D., Deroisy, R., LECART, M.-P., Fontaine, M. A., Collette, J., & Franchimont, P. (1988). Biological and Clinical Assessment of a New Bisphosphonate, (Chloro-4 Phenyl) Thiomethylene Bisphosphonate, in the Treatment of Paget's Disease of Bone. BONE, 9 (6), 349-54. doi:10.1016/8756-3282(88)90115-9 Peer Reviewed verified by ORBi |
 | Lecart, M., JEUGMANS, A.-M., Albert, A., Denis, D., DEROISY, R., Fontaine, M., COLLETTE, J., Reginster, J.-Y., & Franchimont, P. (1988). Effets biologiques et cliniques d'un nouveau bisphosphonate (chloro-4-phényl) thiométhylène bisphosphonate dans la maladie osseuse de Paget. Revue Médicale de Liège, 24, 799-806. Peer reviewed |
 | Desaive, C., Servais, R., COLLETTE, J., Denis, D., Reginster, J.-Y., & Franchimont, P. (1987). Valeur pronostique des marqueurs tumoraux en cas de cancer colo-rectal : CEA et CA 19-9. Acta Gastro-Enterologica Belgica, 40, 65-78. Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Desaive, C., Denis, D., COLLETTE, J., & Franchimont, P. (1985). Dosage pré-opératoire et post-opératoire de l'antigène carcino-embryonnaire : facteur pronostic dans les néoplasies rectocoliques opérées. Revue Médicale de Liège, 40, 85-90. Peer reviewed |
 | Reginster, J.-Y., Desaive, C., COLLETTE, J., Zangerlé, P.-F., Denis, D., & Franchimont, P. (1984). Intérêt du dosage sérique radio-immunologique de l'antigène carcino-embryonnaire dans la surveillance des cancers rectocoliques opérés. Annales de Gastroentérologie et d'Hépatologie, 20, 203-206. Peer reviewed |
 | Reginster, J.-Y., Desaive, C., COLLETTE, J., Zangerlé, P.-F., & Franchimont, P. (1983). La surveillance des cancers rectocoliques opérés, une application pratique du CEA. Revue Médicale de Liège, 38, 581-585. Peer reviewed |